IntegenX, Inc. logo — Automation systems for accurate microsample preparation and...

IntegenX, Inc.

Automation systems for accurate microsample preparation and analysis in life sciences, bringing advanced DNA sequencing and molecular diagnostics within reach.

Founded 2006 United States Pleasanton, United States 21 employees Debt Financing Total: $88.20M Biotechnology, Health Care

General Information

Company Name IntegenX, Inc.
Founded Year 2006
Location United States Pleasanton, United States +1
Employees 21
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

Get notified when IntegenX, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About IntegenX, Inc.

IntegenX, Inc. is a pioneering company in the biotechnology and healthcare industries, specializing in the conception, production, and distribution of automation systems for microsample preparation and analysis in the life sciences field. The company's flagship offerings, including the Apollo 100 platform for DNA sequencing reactions, Apollo 200 system for human DNA identification, microfluidics applications, molecular diagnostics, and human identification solutions, signify its commitment to making advanced DNA sequencing and molecular diagnostics more accessible. Notably, the Apollo 324 system stands out as a benchtop robotic workstation automating the creation of DNA fragment libraries for next-generation sequencing. Formerly known as Microchip Biotechnologies, Inc., the company rebranded to IntegenX, Inc. in March 2010 after being established in 2006 in Pleasanton, California. In 2014, the company secured $10.00M in Debt Financing from Horizon Technology Finance, signifying investor confidence in its innovative solutions and growth potential. IntegenX, Inc.'s dedication to advancing accurate microsample preparation and analysis has positioned it as a key player in enabling breakthroughs within the life sciences sector.

Taxonomy: Automation Systems, Microsample Preparation, DNA Sequencing, Molecular Diagnostics, Life Sciences, Microfluidics, Human DNA Identification, Next-Generation Sequencing, Forensics, Biometrics, Law Enforcement Technology, Criminal Justice Technology, Disaster Victim Identification, Crime Laboratory Technology

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
22 Sep 2014
Series C •••••• 7
Investor Investor Investor Investor Investor
•••• ••••
13 Dec 2011
Series B •••••• 2
Investor
•••• ••••
03 Feb 2011
Series B •••••• - 12 Nov 2009
Series A •••••• - 29 Aug 2006

IntegenX, Inc. Alternatives & Competitors

IntegenX, Inc. vs
DNA Link
DNA Link Korea South

경험을 바탕으로 최고를 만듭니다.

Series Unknown
39 employees
Biotechnology, Pharmaceutical
IntegenX, Inc. vs

Advanced nanowire technology for the biomedical and life science industries

Grant
20 employees
IntegenX, Inc. vs

Empowering Research, Enhancing Lives Through Genomics.

20 employees
Biotechnology, Health Care

FAQ About IntegenX, Inc.

Automation systems for accurate microsample preparation and analysis in life sciences, bringing advanced DNA sequencing and molecular diagnostics within reach.
IntegenX, Inc. was founded in 2006.
IntegenX, Inc. is headquartered in Pleasanton, United States.
IntegenX, Inc. operates in the following industries: Biotechnology, Health Care.
IntegenX, Inc. has approximately 21 employees.
IntegenX, Inc. has completed 5 funding rounds, raising a total of $88.20M. The latest funding stage is Debt Financing.
Top alternatives and competitors to IntegenX, Inc. include DNA Link, Aligned Bio, BMR Genomics, Encodia, SeqLL. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
IntegenX, Inc. and DNA Link are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors IntegenX, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy